---
document_datetime: 2025-04-11 14:20:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/fabhalta-epar-all-authorised-presentations_en.pdf
document_name: fabhalta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8221301
conversion_datetime: 2025-12-28 14:41:16.479487
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate packaging       | Pack size                         |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|-----------------------------------|
| EU/1/24/1802/001 | FABHALTA          | 200 mg     | Capsule, hard         | Oral use                  | blister (PVC/PE/PVDC/alu) | 28 capsules                       |
| EU/1/24/1802/002 | FABHALTA          | 200 mg     | Capsule, hard         | Oral use                  | blister (PVC/PE/PVDC/alu) | 56 capsules                       |
| EU/1/24/1802/003 | FABHALTA          | 200 mg     | Capsule, hard         | Oral use                  | blister (PVC/PE/PVDC/alu) | 168 (3 x 56) capsules (multipack) |